NCT02211924 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Administered to Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02211911 Pharmacokinetics of Bisacodyl or Sodium Picosulfate Administered Orally in Healthy Lactating Females Status COMPLETED Phase PHASE1
NCT02211898 Clinical Study of BNS003 on Swelling in Legs Due to Venous Reflux Status COMPLETED Phase PHASE3
NCT02211885 Excretion Balance of 14c-radiolabeled BIRB 796 BS in Normal Male Subjects Status COMPLETED Phase PHASE1
NCT02211872 BI 2536 BS in Patients With Advanced Solid Tumours and Repeated Administration in Patients With Clinical Benefit Status COMPLETED Phase PHASE1
NCT02211859 Dose Escalation Study of BI 2536 BS in Patients With Advanced Solid Tumours With Repeated Administration in Patients With Clinical Benefit Status COMPLETED Phase PHASE1
NCT02211833 Dose Escalation Study of BI 2536 With Pemetrexed in Previously Treated Patients With Non-small-cell Lung Cancer Status COMPLETED Phase PHASE1
NCT02211170 Effect of Single Oral Dose BIRB 796 BS on Endotoxin-induced Inflammatory Responses in Healthy Human Subjects Status COMPLETED Phase PHASE1
NCT02211157 Safety, Pharmacokinetics and Pharmacodynamics of BIRB 796 BS Tablets Administered to Healthy Human Subjects Status COMPLETED Phase PHASE1
NCT02211144 Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered Twice Daily Orally to Healthy Human Subjects Status COMPLETED Phase PHASE1
NCT02209844 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Rising Oral Doses of BI 44847 Powder in Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02209831 Bioavailability of Oral BIRB 796 BS Tablets With and Without Administration of Oral Pantoprazole in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02209805 Safety and Pharmacokinetics of BIRB 796 BS Tablets Administered to Healthy Human Subjects Status COMPLETED Phase PHASE1
NCT02209792 Dose Finding Study of BIRB 796 BS in Patients With Moderate to Severe Crohn's Disease Status TERMINATED Phase PHASE2
NCT02209779 Efficacy and Safety of Different Doses of BIRB 796 BS in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT02209753 BIRB 796 BS Versus Placebo in Patients With Moderate to Severs Plaque-type Psoriasis Status COMPLETED Phase PHASE2
NCT02209727 Single Dose Escalation Study of 131I-Sibrotuzumab in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Status TERMINATED Phase PHASE1
NCT02209714 Safety, Tolerability and Pharmacodynamics After Oral Administration of BIIF 1149 BS in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02209701 Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors Status TERMINATED Phase PHASE1
NCT02209688 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ESR 1150 CL in Healthy Subjects Status TERMINATED Phase PHASE1